Related Experiment Video
Updated: Aug 30, 2025

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
Self-assembling short immunostimulatory duplex RNAs with broad-spectrum antiviral activity
Longlong Si1, Haiqing Bai1, Crystal Yuri Oh1
1Wyss Institute for Biologically Inspired Engineering, Harvard University, CLSB5, 3 Blackfan Circle, Boston, MA 02115, USA.
Researchers developed novel self-assembling RNA molecules that stimulate the immune system to fight viruses. These short duplex RNAs show broad-spectrum antiviral activity against respiratory viruses, offering potential for new therapeutics.
Area of Science:
- Molecular Biology
- Immunology
- Virology
Background:
- The COVID-19 pandemic underscores the urgent need for effective, broad-spectrum antiviral treatments.
- Current antiviral strategies often target specific viruses, limiting their utility against emerging threats.
Purpose of the Study:
- To describe a new class of self-assembling immunostimulatory short duplex RNAs.
- To investigate their mechanism of action and potential as broad-spectrum antiviral therapeutics.
Main Methods:
- Design and synthesis of novel short duplex RNAs with specific sequence motifs.
- Assessment of interferon (IFN-I and IFN-III) induction in cell lines and human lung chips.
- Evaluation of antiviral activity against SARS-CoV-2, MERS-CoV, HCoV-NL63, and influenza A virus in vitro and in vivo mouse models.
Main Results:
- The novel RNAs self-assemble into dimers and potently induce IFN-I and IFN-III production.
- Their activity is independent of TLR 7/8 but requires the RIG-I/IRF3 pathway, resulting in a lower proinflammatory signature.
- Demonstrated broad-spectrum inhibition of multiple respiratory viruses, including SARS-CoV-2, in various experimental models.
Conclusions:
- These self-assembling short duplex RNAs represent a new class of immunostimulatory agents with significant broad-spectrum antiviral potential.
- Their ease of manufacturing and potent antiviral activity suggest they could be developed into novel therapeutics for respiratory viral infections.
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Viruses with RNA Genomes
Experimental RNAi
Retrovirus Life Cycles
Size and Structure of Viral Genomes

